2022 was a successful year for the European Investment Bank (EIB) Group in Germany, with overall financing increasing by 20% to €6.61 billion compared with the previous year. With the new government dedicated to greening the economy, both private and public companies turned to the EIB for support for long-term investments in renewable energy and energy efficiency projects.
The European Investment Bank (EIB) is investing €15 million in the further development of AI-based human-machine systems designed and manufactured by Augsburg-based tech firm German Bionic. Its smart power suits help logistics and care workers to perform physically strenuous tasks, in particular lifting and carrying heavy loads.
The European Investment Bank (EIB) has signed a quasi-equity financing agreement of up to €20 million with Numares Health AG. The Regensburg-based company has developed a fully automated in-vitro diagnostics (IVD) platform, the AXINON® system. It improves diagnostic quality for chronic diseases of the kidney, heart and liver, as well as cancer and multiple sclerosis.